Navigation Links
Global warming linked to European viral epidemic

An epidemic of the viral disease nephropathia epidemica (NE) has been linked to increases in the vole population caused by hotter summers, milder winters and increased seedcrop production by broadleaf trees. Research published in BioMed Central's open access International Journal of Health Geographics links outbreaks of this rodent-borne disease to known effects of global warming.

Dr Jan Clement from the Department of Microbiology & Immunology at Belgium's Rega Institute (University of Leuven) worked with a team of medical researchers and bioscience-engineers to investigate outbreaks of NE in Belgium. Dr. Clement founded the Belgian Hantavirus Reference Centre in 1985, and noted that of the 2,200 cases since then, 828 (37.6%) occurred in just the last three years, 2005-2007. The epidemic has been shown to extend to neighboring countries such as France, Germany, The Netherlands, and Luxembourg. He said, "This animal-borne disease, scarcely known before 1990, has been increasing in incidence in Belgium with a cyclic pattern, reaching epidemic proportions since 2005. The fact that the growing combined effect of hotter summer and autumn seasons is matched by the growth of NE in recent years means this epidemic can be considered an effect of global warming".

NE is caused by infection with Puumala virus (PUUV), which is spread by the bank vole, a rodent common throughout most of Europe. The authors believe that warmer weather causes increases in the amount of 'mast', plant seeds from oak and beech trees, that forms the voles' staple diet. This plethora of food results in increases in the vole population and warm summers raise the chances that people will visit the forests where the voles live. According to Clement, "Since 1993, each NE peak has been preceded by increased autumnal mast formation the year before, resulting in yearly NE numbers significantly higher than those during the mast years themselves".

PUUV is a hantavirus, a group of viruses known to cause hemorrhagic fevers (fevers combined with bleeding disorders). NE is a relatively mild hemorrhagic fever that causes flu-like symptoms often with renal complications, sometimes also with pulmonary problems, needing Intensive Care treatment, such as acute dialysis and/or mechanical ventilation. In some rare cases it can, moreover, cause the shock with internal haemorrhaging and death for which these infections are infamous. Clement said, "In 1997, more than 9,000 people in the Russian republic of Bashkortostan contracted the disease, of which 34 cases were fatal".


Contact: Graeme Baldwin
BioMed Central

Related biology news :

1. Decline of carbon-dioxide-gobbling plankton coincided with ancient global cooling
2. Lifecycles of tropical cyclones predicted in global computer model
3. USC researchers head global effort to study genetic risks that contribute to psychiatric diseases
4. Using water to understand human society, from the industrial revolution to global trade
5. Light pollution offers new global measure of coral reef health
6. Global warming is changing organic matter in soil
7. Issues at intersection of climate change and health impact global well-being
8. UI researchers help to improve carbon measurements in global climate studies
9. Global warming link to amphibian declines in doubt
10. Less than one month to opening of world’s largest global congress on osteoporosis
11. Global warming predicted to hasten carbon release from peat bogs
Post Your Comments:
(Date:11/19/2015)... YORK , Nov. 19, 2015  Although some ... market is dominated by a few companies, according to ... companies own 51% of the market share of the ... The World Market for Molecular Diagnostic s ... "The market is still controlled by one company ...
(Date:11/17/2015)... LIVERMORE, Calif. , Nov. 17, 2015  Vigilant ... has joined its Board of Directors. ... Vigilant,s Board after recently retiring from the partnership at ... owning 107 companies with over $140 Billion in revenue.  ... performance improvement across all the TPG companies, from 1997 ...
(Date:11/12/2015)... , Nov. 11, 2015   Growing need ... analytical tools has been paving the way for ... determination of discrete analytes in clinical, agricultural, environmental, ... being predominantly used in medical applications, however, their ... sectors due to continuous emphasis on improving product ...
Breaking Biology News(10 mins):
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... Program that includes over 2,000 technical presentations offered in symposia, oral sessions, ... and applied spectroscopy, covers a wide range of applications such as, but not ...
(Date:11/25/2015)... ANNAPOLIS, Md. , Nov. 25, 2015  PharmAthene, ... of Directors has adopted a stockholder rights plan (Rights ... its net operating loss carryforwards (NOLs) under Section 382 ... --> --> PharmAthene,s use of its ... an "ownership change" as defined in Section 382 of ...
(Date:11/25/2015)... QUEBEC CITY , Nov. 25, 2015 /PRNewswire/ ... "Company"), affirms that its business and prospects remain ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB ... program to completion following review of the final ... met Phase 2 Primary Endpoint in men with ...
(Date:11/24/2015)... 24, 2015  Asia-Pacific (APAC) holds the third-largest ... market. The trend of outsourcing to low-cost locations ... higher volume share for the region in the ... margins in the CRO industry will improve. ... ( ), finds that the market earned ...
Breaking Biology Technology: